Golimumab
Drug timelines are a Plus or Pro feature.
45 regulatory and trial events tracked for Golimumab, covering 2011-09-28 to 2026-07-23. Get the full timeline:
Most recent: Clinical Trial Results: A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis [Phase 2]